Condensed Statement of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Shareholders' deficiency, Beginning balance at Jan. 31, 2013	$ (173,758)	$ 1,233	$ 81,323	$ (213,038)	$ (43,276)
Common stock, shares outstanding, Beginning balance at Jan. 31, 2013	1,233,853	1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(70,492)	0	0	0	(70,492)
Shareholders' deficiency, Ending balance at Oct. 31, 2013	$ (244,250)	$ 1,233	$ 81,323	$ (213,038)	$ (113,768)
Common stock, shares outstanding, Ending balance at Oct. 31, 2013	1,233,853	1,233,853